3[4]Iwashima Y,Horio T,Kamide K,et al.Left ventricular massindex,and risk of cardiovascular disease in essential hypertension[J].Hypertension,2006,47(2):195-202. 被引量：1
4Brand FN, Megee DL, Kannel, WB, et al. Hyperuricenmia as a risk of coronary heart disease: the framingham study. Am J Epidemiol,1985,121:11-18. 被引量：1
5Freedam DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The nhanesi epidemiologic follow up study. Am J Epidemiol, 1995,141:637-644. 被引量：1
6Puddu PE, Lanti M, Menotti A, et al. Sermn uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study. Acta Cardiol, 2001,56:243-251. 被引量：1
7Gertler MM, Garn SM, Levine SA. Serum Uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med, 1951,34 : 1421-1431. 被引量：1
8Beard Jt. Serum uric acid and coronary heart disease. Am Heart J,1983,106:397-400. 被引量：1
9Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients.Hypertension, 1999,34 : 144-150. 被引量：1
10Bickel C, Rupprecht HI, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographical]y proven coronary artery disease. Am J Cardiol, 2002,89:12-17. 被引量：1
2Viera AJ,Sheridan SL.Global risk of coronary heart disease:assessment and application.Am Fam Physician,2010,82(3):265～274. 被引量：1
3Geng H,Wang A,Rong G,et al.The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway.Mol Cell Biochem,2010,342(1-2):201～206. 被引量：1
4Natarajan P,Ray KK,Cannon CP.High-density lipoprotein and coronary heart disease:current and future therapies.J Am Coll Cardiol,2010,55(13):1283～1299. 被引量：1
6Caspi D,Lubart E,Graft E,et al. The effect of mini-dose aspirin onrenal function and uric acid handling in elderly patients[ J]. ArthritisRheummatism,2001,43( 1) -.103-108. 被引量：1
